Central Pharmaceuticals Ltd. (DSE:CENTRALPHL)
8.50
-0.40 (-4.49%)
At close: Mar 3, 2026
Central Pharmaceuticals Market Cap
Central Pharmaceuticals has a market cap or net worth of 1.03 billion as of March 4, 2026. Its market cap has decreased by -27.12% in one year.
Market Cap
1.03B
Enterprise Value
1.30B
Revenue
33.51M
Ranking
n/a
PE Ratio
n/a
Stock Price
8.50
Market Cap Chart
Since August 14, 2013, Central Pharmaceuticals's market cap has decreased from 2.38B to 1.03B, a decrease of -56.73%. That is a compound annual growth rate of -6.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 1.02B | -1.16% |
| Dec 30, 2025 | 1.03B | -3.37% |
| Dec 30, 2024 | 1.07B | -55.94% |
| Dec 28, 2023 | 2.42B | 69.75% |
| Dec 29, 2022 | 1.43B | -9.85% |
| Dec 30, 2021 | 1.58B | 9.09% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Asiatic Laboratories | 7.64B |
| Orion Pharma | 7.04B |
| Navana Pharmaceuticals | 6.27B |
| Techno Drugs | 3.92B |
| Ambee Pharmaceuticals | 1.79B |
| Pharma Aids | 1.67B |
| Indo-Bangla Pharmaceuticals | 1.56B |
| Libra Infusions | 1.42B |